TLOG Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (13 Dec 2023 @ 15:25):

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases...

Stats
Today's Volume	100.00
Average Volume	0.00
Market Cap	458 720
EPS	$-0.0800 ( 2016-11-03 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.0100
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2016-11-14	Highbridge Capital Management Llc	Buy	0
2016-11-14	Whitebox Advisors Llc	Buy	3 018 260	Preferred Stock
2016-11-14	Whitebox Advisors Llc	Sell	0	8% Senior Convertible Notes due 2019
2016-11-14	Whitebox Advisors Llc	Buy	0	8% Senior Convertible Notes due 2024
2016-11-14	Hudson Bay Capital Management Lp	Buy	279 367	Preferred Stock

INSIDER POWER
0.00
Last 89 transactions
Buy: 6 009 229 \| Sell: 2 506 005

Volume Correlation

Long: -0.38 (neutral)

Short: 0.00 (neutral)

Signal:(51.836) Neutral

TetraLogic Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

TetraLogic Correlation - Currency/Commodity

0.00
( neutral )

TetraLogic Financials

Annual	2022
Revenue:	$0
Gross Profit:	$0 (0.00 %)
EPS:	$0

Q3	2016
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.350

Q2	2016
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.270

Q1	2016
Revenue:	$0.00
Gross Profit:	$0.00 (0.00 %)
EPS:	$-0.450

Financial Reports:

No articles found.

TetraLogic

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.